Massive Bio Expands Free Cancer Trials Access in Balkans
A New Chapter in Precision Oncology
Precision oncology is rapidly transforming the landscape of cancer treatment. At the forefront of this evolution stands Massive Bio, a New York-based company leveraging AI to match cancer patients with clinical trials worldwide.
What’s less known is the company’s strategic collaboration with Asklepieia, a pioneer in integrating healthcare, wellness, and hospitality services for health tourism, primarily in Greece.
This powerful alliance, already active in Greece, is now expanding to Romania, Bulgaria, Albania, and North Macedonia—a monumental step toward revolutionizing oncology access across Southeast Europe.
Why Clinical Trial Access in the Balkans Is More Crucial Than Ever
Clinical trials represent hope. They provide access to cutting-edge therapies often unavailable through standard care—especially critical for patients with advanced or treatment-resistant cancers.
The Balkan region is becoming increasingly involved in clinical research:
• Romania and Bulgaria are emerging as European clinical trial hubs.
• North Macedonia and Albania are engaging steadily, mainly via their capital cities.
• These countries offer a strong healthcare infrastructure and cost-effective environments for research.
Yet challenges persist:
Patients often face complex processes, high administrative fees, and limited information when trying to join a trial.
The Asklepieia–Massive Bio Difference: 100% Free and Patient-Centered
This collaboration marks a paradigm shift:
• The Massive Bio Clinical Network is entirely free for physicians and patients.
• Asklepieia Health covers all administrative costs for uploading medical records.
• Patients face zero financial burden to receive trial matching.
• Physicians gain access to a robust, AI-powered tool without the red tape.
Are you a physician? Join the Massive Bio Clinical Network and refer patients now.
Are you a patient or caregiver? Find out if you’re eligible for a free clinical trial.
What Is the Massive Bio Clinical Network?
It’s a secure, AI-driven platform that matches cancer patients to the most suitable clinical trials globally, based on their medical records and cancer profile.
Once medical records are uploaded (in compliance with all data privacy regulations), Massive Bio’s scientific team and its proprietary AI, Dr. Arturo, analyze the data to propose tailored trial options.
Key Features:
• Trial Matching at No Cost: No fees for patients or physicians
• Real-Time Updates: Progress tracking for referring doctors
• GDPR, HIPAA & PIPEDA Compliance: Automatic anonymization and consent-based data usage
• Concierge-Level Support: Appointment scheduling, translations, travel help, and financial navigation
• Applicable for Many Cancer Types:
Including Lung Cancer, Breast Cancer, Multiple Myeloma, Liver Cancer, Colorectal Cancer, HNSCC, Lymphoma, Leukemia, and more
Upload a medical record to get started.
Empowering Doctors and Patients Across the Region
This expansion aims to make a meaningful, measurable difference in the lives of patients across the Balkans. Our vision includes:
• Raising awareness in medical communities
• Providing easy-to-use tools for trial enrollment
• Ensuring that no patient is denied access due to cost
Massive Bio and Asklepieia are committed to removing barriers and enabling equal access to cutting-edge cancer care.
Ready to Take Action?
Let’s Transform Cancer Care Together
With this joint initiative across Greece, Romania, Albania, North Macedonia, and Bulgaria, we’re not just offering access—we’re offering hope.
No cost. No delay. No barrier.
Just the opportunity to access life-saving therapies through trusted, expert-guided channels.
